$CLSD
Clearside Biomedical, Inc.

2017 Q1 Form 10-K Financial Statement

#000156459017004643 Filed on March 16, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 2015 Q4
Revenue $5.000K $520.0K $0.00
YoY Change -99.01%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.670M $6.260M $1.220M
YoY Change 110.24% -4.57% 67.12%
% of Gross Profit
Research & Development $7.590M $19.46M $3.800M
YoY Change 65.4% 80.77% 97.92%
% of Gross Profit
Depreciation & Amortization $30.00K $65.00K $10.00K
YoY Change 76.47% 8.33% 0.0%
% of Gross Profit
Operating Expenses $10.26M $25.72M $5.016M
YoY Change 75.04% 48.51% 89.28%
Operating Profit -$10.26M -$25.20M
YoY Change 91.45% 45.51%
Interest Expense -$150.0K
YoY Change 1400.0%
% of Operating Profit
Other Income/Expense, Net -$117.0K -$684.0K
YoY Change 27.17% 112.42%
Pretax Income -$10.37M -$25.88M -$5.170M
YoY Change 90.28% 46.71% 94.36%
Income Tax
% Of Pretax Income
Net Earnings -$10.37M -$25.88M -$5.170M
YoY Change 90.37% 46.73% 94.36%
Net Earnings / Revenue -207460.0% -4977.31%
Basic Earnings Per Share
Diluted Earnings Per Share -$410.7K -$1.023M -$263.9K
COMMON SHARES
Basic Shares Outstanding 25.29M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $77.50M $83.63M $20.30M
YoY Change 387.42% 312.38%
Cash & Equivalents $22.99M $34.82M $20.28M
Short-Term Investments $54.50M $48.81M
Other Short-Term Assets $3.000M $690.0K $40.00K
YoY Change 2900.0% 245.0%
Inventory
Prepaid Expenses $159.0K
Receivables
Other Receivables
Total Short-Term Assets $80.50M $84.32M $20.48M
YoY Change 403.13% 311.72%
LONG-TERM ASSETS
Property, Plant & Equipment $1.000M $90.00K $156.0K
YoY Change 900.0% -43.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $500.0K $400.0K $7.000K
YoY Change -37.5% -4.76%
Total Long-Term Assets $1.500M $490.0K $573.0K
YoY Change 66.67% -15.52%
TOTAL ASSETS
Total Short-Term Assets $80.50M $84.32M $20.48M
Total Long-Term Assets $1.500M $490.0K $573.0K
Total Assets $82.00M $84.81M $21.06M
YoY Change 385.21% 302.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.700M $2.590M $1.469M
YoY Change 88.0% 76.19%
Accrued Expenses $1.500M $2.790M $1.985M
YoY Change -40.0% 40.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $800.0K $1.733M
YoY Change -65.22%
Total Short-Term Liabilities $7.200M $5.410M $5.196M
YoY Change -1.37% 4.04%
LONG-TERM LIABILITIES
Long-Term Debt $6.900M $7.590M $4.243M
YoY Change 86.49% 79.01%
Other Long-Term Liabilities $700.0K $160.0K $261.0K
YoY Change 75.0% -83.33%
Total Long-Term Liabilities $7.600M $7.750M $4.504M
YoY Change 85.37% 49.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.200M $5.410M $5.196M
Total Long-Term Liabilities $7.600M $7.750M $4.504M
Total Liabilities $14.80M $13.15M $10.40M
YoY Change 29.82% 26.44%
SHAREHOLDERS EQUITY
Retained Earnings -$39.36M
YoY Change
Common Stock $3.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $67.20M $71.66M -$36.66M
YoY Change
Total Liabilities & Shareholders Equity $82.00M $84.81M $21.06M
YoY Change 385.21% 302.71%

Cashflow Statement

Concept 2017 Q1 2016 2015 Q4
OPERATING ACTIVITIES
Net Income -$10.37M -$25.88M -$5.170M
YoY Change 90.37% 46.73% 94.36%
Depreciation, Depletion And Amortization $30.00K $65.00K $10.00K
YoY Change 76.47% 8.33% 0.0%
Cash From Operating Activities -$10.98M -$22.71M -$3.830M
YoY Change 149.55% 63.37% 41.33%
INVESTING ACTIVITIES
Capital Expenditures $309.0K $3.000K -$20.00K
YoY Change -90.63% -71.43%
Acquisitions
YoY Change
Other Investing Activities -$5.680M -$49.14M $0.00
YoY Change
Cash From Investing Activities -$5.990M -$49.14M -$30.00K
YoY Change 163700.0% -57.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $6.330M
YoY Change
Cash From Financing Activities 5.130M 86.39M 19.95M
YoY Change 233.04% -99850.0%
NET CHANGE
Cash From Operating Activities -10.98M -22.71M -3.830M
Cash From Investing Activities -5.990M -49.14M -30.00K
Cash From Financing Activities 5.130M 86.39M 19.95M
Net Change In Cash -11.84M 14.54M 16.09M
YoY Change 168.98% 21.07% -674.64%
FREE CASH FLOW
Cash From Operating Activities -$10.98M -$22.71M -$3.830M
Capital Expenditures $309.0K $3.000K -$20.00K
Free Cash Flow -$11.29M -$22.71M -$3.810M
YoY Change 156.57% 63.02% 44.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
48807000
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
159000
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
40000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
20482000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
156000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
94000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
360000
CY2015Q4 us-gaap Liabilities
Liabilities
10400000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7000
CY2016Q4 us-gaap Assets
Assets
84813000
CY2015Q4 us-gaap Assets
Assets
21055000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2594000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1469000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2791000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1985000
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1733000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5196000
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
396000
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
290000
CY2016Q4 us-gaap Liabilities
Liabilities
13154000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
84317000
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7586000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
160000
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Trading Symbol
TradingSymbol
CLSD
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0001539029
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
47314000
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016 dei Entity Registrant Name
EntityRegistrantName
Clearside Biomedical, Inc.
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
25000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
136892000
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65245000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13000
CY2016 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25286016
CY2016Q2 dei Entity Public Float
EntityPublicFloat
44137000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34824000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20283000
CY2015Q4 us-gaap Deferred Costs
DeferredCosts
410000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
261000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
71659000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84813000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21055000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5408000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
23000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6692000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10762000
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3131000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-17639000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
145000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2701000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39363000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-36659000
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-322000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19455000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-25198000
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6263000
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6555000
CY2016 us-gaap Operating Expenses
OperatingExpenses
25718000
CY2015 us-gaap Operating Expenses
OperatingExpenses
17317000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-17317000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-9823000
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-366000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-10189000
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4243000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
427000
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
200000
CY2016 clsd Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
9000
CY2015 clsd Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
9000
CY2014 clsd Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
9000
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24573033
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24573033
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2659262
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2659262
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
705000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
427000
CY2016 us-gaap Paid In Kind Interest
PaidInKindInterest
283000
CY2015 us-gaap Paid In Kind Interest
PaidInKindInterest
104000
CY2014 us-gaap Paid In Kind Interest
PaidInKindInterest
82000
CY2016 us-gaap Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1
DeferredFinanceCostsOwnShareLendingArrangementIssuanceCostsAmortizationExpense1
108000
CY2015 us-gaap Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1
DeferredFinanceCostsOwnShareLendingArrangementIssuanceCostsAmortizationExpense1
60000
CY2014 us-gaap Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1
DeferredFinanceCostsOwnShareLendingArrangementIssuanceCostsAmortizationExpense1
277000
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
156000
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
52000
CY2014 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
18000
CY2016 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
43000
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-15000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
487000
CY2016 us-gaap Licenses Revenue
LicensesRevenue
520000
CY2014 us-gaap Operating Expenses
OperatingExpenses
9823000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-684000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-25882000
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.97
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.54
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.86
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13111067
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2338950
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1738660
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-13000
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25895000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17639000
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10189000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-10737000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
CY2014 clsd Restricted Stock Vested Value
RestrictedStockVestedValue
6000
CY2014 clsd Issuance Of Warrant To Purchase Common Stock
IssuanceOfWarrantToPurchaseCommonStock
1506000
CY2014 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
231000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-19213000
CY2015 clsd Issuance Of Common Stock Upon Exercise Of Warrants
IssuanceOfCommonStockUponExerciseOfWarrants
-1000
CY2015 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
525000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
705000
CY2016 clsd Issuance Of Common Stock Upon Exercise Of Warrants
IssuanceOfCommonStockUponExerciseOfWarrants
410000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
51377000
CY2016 clsd Stock Issued During Period Value Follow On Offering
StockIssuedDuringPeriodValueFollowOnOffering
33459000
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
48198000
CY2016 clsd Issuance Of Warrant To Purchase Common Stock
IssuanceOfWarrantToPurchaseCommonStock
308000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1314000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13000
CY2016 us-gaap Depreciation
Depreciation
65000
CY2015 us-gaap Depreciation
Depreciation
60000
CY2014 us-gaap Depreciation
Depreciation
33000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
1314000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-54000
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-882000
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1763000
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1154000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1424000
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
632000
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1137000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-520000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
500000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-22709000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-13902000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9124000
CY2016 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
54485000
CY2016 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
5708000
CY2016 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
360000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
140000
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-49140000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-28000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-140000
CY2016 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
51376000
CY2016 clsd Proceeds From Issuance Follow On Offering
ProceedsFromIssuanceFollowOnOffering
33456000
CY2016 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
7857000
CY2015 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5976000
CY2014 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3000000
CY2016 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6330000
CY2014 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
125000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
31000
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14000
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
86390000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
25944000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
15624000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14541000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12014000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6360000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8269000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1909000
CY2016 us-gaap Interest Paid
InterestPaid
250000
CY2015 us-gaap Interest Paid
InterestPaid
100000
CY2014 us-gaap Interest Paid
InterestPaid
7000
CY2016 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
48198000
CY2014 clsd Conversion Of Stockholder Loan Promissory Note And Accrued Interest
ConversionOfStockholderLoanPromissoryNoteAndAccruedInterest
3232000
CY2016 clsd Reclassification Of Deferred Initial Public Offering Costs
ReclassificationOfDeferredInitialPublicOfferingCosts
1597000
CY2015 clsd Issuance Of Warrant To Purchase Preferred Stock
IssuanceOfWarrantToPurchasePreferredStock
164000
CY2016 clsd Accretion Of Redeemable Convertible Preferred Stock To Redemption Value
AccretionOfRedeemableConvertiblePreferredStockToRedemptionValue
884000
CY2015 clsd Accretion Of Redeemable Convertible Preferred Stock To Redemption Value
AccretionOfRedeemableConvertiblePreferredStockToRedemptionValue
525000
CY2014 clsd Accretion Of Redeemable Convertible Preferred Stock To Redemption Value
AccretionOfRedeemableConvertiblePreferredStockToRedemptionValue
231000
CY2016 clsd Deferred Initial Public Offering Costs In Accounts Payable And Accrued Expenses
DeferredInitialPublicOfferingCostsInAccountsPayableAndAccruedExpenses
507000
CY2015 clsd Deferred Initial Public Offering Costs In Accounts Payable And Accrued Expenses
DeferredInitialPublicOfferingCostsInAccountsPayableAndAccruedExpenses
410000
CY2014 clsd Deferred Initial Public Offering Costs In Accounts Payable And Accrued Expenses
DeferredInitialPublicOfferingCostsInAccountsPayableAndAccruedExpenses
602000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
3000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
4000
CY2016Q4 clsd Deferred Tax Assets Deferred Income Current
DeferredTaxAssetsDeferredIncomeCurrent
8000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance Current
DeferredTaxAssetsValuationAllowanceCurrent
367000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance Current
DeferredTaxAssetsValuationAllowanceCurrent
233000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance Current
DeferredTaxAssetsValuationAllowanceCurrent
24000
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of income and expenses during the reporting periods. Significant items subject to such estimates and assumptions include the accounting for useful lives to calculate depreciation and amortization, clinical trial accruals, share-based compensation expense and income tax valuation allowance. Actual results could differ from these estimates.</p></div>
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk Arising From Cash Deposits in Excess of Insured Limits</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The Company maintains its cash in bank deposits that at times may exceed federally insured limits. The Company has not experienced any loss in such accounts. The Company believes it is not exposed to any significant risks with respect to its cash balances.</p></div>
CY2016 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2011-05-26
CY2016 clsd Public Offering Closing Date
PublicOfferingClosingDate
2016-12-14
CY2016Q4 clsd Stock Issued During Period Shares Follow On Offering
StockIssuedDuringPeriodSharesFollowOnOffering
4000000
CY2016Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
9.00
CY2016Q4 clsd Stock Issued During Period Value Follow On Offering
StockIssuedDuringPeriodValueFollowOnOffering
33400000
CY2016 clsd Underwriting Discounts And Commissions
UnderwritingDiscountsAndCommissions
2500000
CY2016 clsd Offering Expense
OfferingExpense
400000
CY2016 clsd Proceeds From Issuance Of Convertible Preferred Stock And Long Term Debt
ProceedsFromIssuanceOfConvertiblePreferredStockAndLongTermDebt
53900000
CY2016Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
83600000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
55800000
CY2016 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Operating Income Loss
OperatingIncomeLoss
23300000
CY2016Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.4545
CY2016 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On May 11, 2016, the Company effected a 1-for-2.2 reverse stock split of its issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each series of the Company’s convertible preferred stock.
CY2016 clsd Short Term Investments Maturity Period Range Start
ShortTermInvestmentsMaturityPeriodRangeStart
P90D
CY2016 clsd Short Term Investments Maturity Period Range End
ShortTermInvestmentsMaturityPeriodRangeEnd
P365D
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
262000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
259000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
168000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
103000
CY2016Q4 clsd Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
1153000
CY2015Q4 clsd Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
569000
CY2016Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
870000
CY2015Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
530000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
410000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
668000
CY2016Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
72000
CY2015Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
64000
CY2016Q4 us-gaap Interest Payable Current
InterestPayableCurrent
52000
CY2015Q4 us-gaap Interest Payable Current
InterestPayableCurrent
15000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
234000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
139000
CY2016 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
287000
CY2015 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
115000
CY2016 clsd Accretion Of Final Payment Of Amount Borrowed
AccretionOfFinalPaymentOfAmountBorrowed
283000
CY2015 clsd Accretion Of Final Payment Of Amount Borrowed
AccretionOfFinalPaymentOfAmountBorrowed
101000
CY2016 clsd Accretion Of Deferred Closing Costs
AccretionOfDeferredClosingCosts
17000
CY2015 clsd Accretion Of Deferred Closing Costs
AccretionOfDeferredClosingCosts
7400
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3200000
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
3200000
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1600000
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
8000000
CY2016Q4 clsd Long Term Debt Maturities Repayments Of Interest And Final Payment In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfInterestAndFinalPaymentInNextTwelveMonths
608000
CY2016Q4 clsd Long Term Debt Maturities Repayments Of Interest And Final Payment In Year Two
LongTermDebtMaturitiesRepaymentsOfInterestAndFinalPaymentInYearTwo
476000
CY2016Q4 clsd Long Term Debt Maturities Repayments Of Interest And Final Payment In Year Three
LongTermDebtMaturitiesRepaymentsOfInterestAndFinalPaymentInYearThree
234000
CY2016Q4 clsd Long Term Debt Maturities Repayments Of Interest And Final Payment In Year Four
LongTermDebtMaturitiesRepaymentsOfInterestAndFinalPaymentInYearFour
545000
CY2016Q4 clsd Long Term Debt Maturities Repayments Of Interest And Final Payment
LongTermDebtMaturitiesRepaymentsOfInterestAndFinalPayment
1863000
CY2016Q4 clsd Long Term Debt Maturities Repayments Of Principal Interest And Final Payment In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFinalPaymentInNextTwelveMonths
608000
CY2016Q4 clsd Long Term Debt Maturities Repayments Of Principal Interest And Final Payment In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFinalPaymentInYearTwo
3676000
CY2016Q4 clsd Long Term Debt Maturities Repayments Of Principal Interest And Final Payment In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFinalPaymentInYearThree
3434000
CY2016Q4 clsd Long Term Debt Maturities Repayments Of Principal Interest And Final Payment In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFinalPaymentInYearFour
2145000
CY2016Q4 clsd Long Term Debt Maturities Repayments Of Principal Interest And Final Payment
LongTermDebtMaturitiesRepaymentsOfPrincipalInterestAndFinalPayment
9863000
CY2016Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
9614159
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2013Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
11871000
CY2014 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
11501000
CY2014 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3232000
CY2014 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
231000
CY2014Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
26835000
CY2015 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
19954000
CY2015 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
525000
CY2016 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
884000
CY2014Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
2.69783
CY2016Q4 clsd Deferred Tax Assets Tax Non Deductible Accruals Accrued Expenses
DeferredTaxAssetsTaxNonDeductibleAccrualsAccruedExpenses
358000
CY2015Q4 clsd Deferred Tax Assets Tax Non Deductible Accruals Accrued Expenses
DeferredTaxAssetsTaxNonDeductibleAccrualsAccruedExpenses
230000
CY2014Q4 clsd Deferred Tax Assets Tax Non Deductible Accruals Accrued Expenses
DeferredTaxAssetsTaxNonDeductibleAccrualsAccruedExpenses
20000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
1000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
70000
CY2016Q4 clsd Non Current Deferred Tax Assets Accelerated Depreciation
NonCurrentDeferredTaxAssetsAcceleratedDepreciation
13000
CY2015Q4 clsd Non Current Deferred Tax Assets Accelerated Depreciation
NonCurrentDeferredTaxAssetsAcceleratedDepreciation
28000
CY2014Q4 clsd Non Current Deferred Tax Assets Accelerated Depreciation
NonCurrentDeferredTaxAssetsAcceleratedDepreciation
31000
CY2016Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
61000
CY2015Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
77000
CY2014Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
0
CY2015Q4 clsd Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent Non Current
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRentNonCurrent
1000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9700000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7000000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
0
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
0
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
0
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23391000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14119000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7891000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
101000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
88000
CY2014Q4 clsd Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent Non Current
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRentNonCurrent
4000
CY2016Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
6000
CY2015Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
3000
CY2014Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
3000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
25079000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
15372000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
8580000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
0
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3400
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0379
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0454
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0441
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0198
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0126
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0115
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0162
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0266
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0454
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3743
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3994
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.4180
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4200000
CY2016 clsd Deferred Tax Assets Operating Loss Carryforwards Expiration Year
DeferredTaxAssetsOperatingLossCarryforwardsExpirationYear
2035
CY2016 clsd Non Cancelable Operating Leases Expiration Month And Year
NonCancelableOperatingLeasesExpirationMonthAndYear
2017-03
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
128000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
431000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
444000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
458000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
472000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
860000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2793000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
81000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
150000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
198000
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
48820000
CY2016Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
13000
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
83991000
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2273371
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10886950
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9094859
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
5862000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
5183000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
5311000
CY2016Q4 us-gaap Operating Expenses
OperatingExpenses
9362000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-5449000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-5102000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-5645000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-9686000
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.05
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.62
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
3757000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
5170000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
3374000
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
5016000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-3757000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-5327000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-3475000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-5170000
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.07
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.36
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.31
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.95

Files In Submission

Name View Source Status
0001564590-17-004643-index-headers.html Edgar Link pending
0001564590-17-004643-index.html Edgar Link pending
0001564590-17-004643.txt Edgar Link pending
0001564590-17-004643-xbrl.zip Edgar Link pending
clsd-10k_20161231.htm Edgar Link pending
clsd-20161231.xml Edgar Link completed
clsd-20161231.xsd Edgar Link pending
clsd-20161231_cal.xml Edgar Link unprocessable
clsd-20161231_def.xml Edgar Link unprocessable
clsd-20161231_lab.xml Edgar Link unprocessable
clsd-20161231_pre.xml Edgar Link unprocessable
clsd-ex1021_665.htm Edgar Link pending
clsd-ex231_624.htm Edgar Link pending
clsd-ex311_6.htm Edgar Link pending
clsd-ex312_8.htm Edgar Link pending
clsd-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2017031618111319342317.jpg Edgar Link pending
g2017031618111319942318.jpg Edgar Link pending
g2017031618111322042319.jpg Edgar Link pending
g2017031618111323242320.jpg Edgar Link pending
g2017031618111326742321.jpg Edgar Link pending
g2017031618111328142322.jpg Edgar Link pending
g2017031618111328342323.jpg Edgar Link pending
g2017031618111328642324.jpg Edgar Link pending
g2017031618111328942325.jpg Edgar Link pending
g2017031618111329242326.jpg Edgar Link pending
g2017031618111329542327.jpg Edgar Link pending
g2017031618111330842328.jpg Edgar Link pending
g2017031618111331842329.jpg Edgar Link pending
g2017031618111356142330.jpg Edgar Link pending
g2017031618112449542331.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending